ECM Therapeutics, Inc.

ECM Therapeutics, Inc.

生物技术研究

Warrendale,Pennsylvania 351 位关注者

Restoring health and functional tissues with extracellular matrix-based signaling molecules

关于我们

Advancing regenerative medicine through the development of a natural biomaterial that restores mother nature’s template to treat disease and injury. ECM scaffolds, in solid form, have been successfully used in more than 10 million human patients to repair a variety of body systems such as musculoskeletal tissues, cardiovascular structures, and non-healing skin wounds, among others. These products have all received FDA clearance. ECM Therapeutics' patented ECM hydrogel technology allows for expanded, less invasive applications in multiple disease areas. The first clinical product, EsophaGel, treats Barrett’s esophagus, a precancerous condition that currently has no effective therapy.

网站
https://www.ecmtherapeutics.com
所属行业
生物技术研究
规模
2-10 人
总部
Warrendale,Pennsylvania
类型
私人持股
创立
2018

地点

  • 主要

    118 Marshall Drive

    US,Pennsylvania,Warrendale,13086

    获取路线

ECM Therapeutics, Inc.员工

动态

相似主页

查看职位

融资

ECM Therapeutics, Inc. 共 2 轮

上一轮

未知

US$15,924,006.00

Crunchbase 上查看更多信息